Completed NA INTERVENTIONAL 4-arm NCT01793779

Comparison of Pre-exercise Beta-hydroxy-beta-methylbutyrate Free Acid (HMB-FA) and Cold Water Therapy for the Attenuation of Muscle Damage and Soreness

Comparison of Pre-exercise Beta-hydroxy-beta-methylbutyrate Free Acid (HMB-FA) and Cold Water Therapy for the Attenuation of Muscle Damage and Soreness in Experienced Resistance Trained Individuals.

Sponsor: Metabolic Technologies Inc.

Conditions Muscle Damage

Interventions Placebo beta-hydroxy-beta-methylbutyrate free acid (HMB-FA) cold water immersion

Updated 5 times since 2017 Last updated: Jul 31, 2013 Started: Dec 31, 2012 Primary completion: Apr 30, 2013 Completion: Apr 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Muscle Damage, this trial is completed. The trial is conducted by Metabolic Technologies Inc. and has accumulated 5 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Metabolic Technologies Inc.

Data source: Metabolic Technologies Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Orlando, United States